Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL197294 | 0.75 | ALDH1A1 (0.36) | ALDH1A1LMNAMAPTHPGDRAB9A | |
| SCHEMBL27627751 | 0.71 | ALDH1A1 (0.36) | ALDH1A1LMNAMAPTHPGDRAB9A | |
| SCHEMBL1245015 | 0.71 | ALDH1A1 (0.40) | ALDH1A1LMNAMAPTHPGDRAB9A | |
| SCHEMBL7283734 | 0.65 | USP2 (0.47) | ALDH1A1LMNAMAPTRAB9AKMT2A | |
| SCHEMBL9533796 | 0.63 | ALDH1A1 (0.47) | ALDH1A1RAB9AKMT2ANPSR1 | |
| SCHEMBL1363734 | 0.62 | — | — | |
| SCHEMBL16346426 | 0.62 | — | — | |
| SCHEMBL28252200 | 0.62 | — | — | |
| SCHEMBL4805804 | 0.62 | — | — | |
| SCHEMBL1750437 | 0.62 | MAPT (0.39) | ALDH1A1LMNAMAPTHPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1075476-B1 | NOVEL BENZIMIDAZOLES AND BENZOXAZOLES | ALTANA PHARMA AG (DE) | 2003-06-04 | — | — | EP | claimed |
| US-6294564-B1 | ACUTE OR CHRONIC AIRWAY DISORDER, A DERMATOSIS, A DISORDER BASED ON EXCESSIVE RELEASE OF TNF OR LEIKOTRIENE, A DISORDER OF GRAFT-VERSUS-HOST REACTION, A TRANSPLANT REJECTION REACTION, A SYMPTOM OF SHOCK, A GENERALIZED INFLAMMATION IN | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 2001-09-25 | — | — | US | claimed |
| EP-1075476-A1 | NOVEL BENZIMIDAZOLES AND BENZOXAZOLES | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 2001-02-14 | — | — | EP | claimed |
| WO-1999057115-A1 | NOVEL BENZIMIDAZOLES AND BENZOXAZOLES | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1999-11-11 | — | — | WO | claimed |
| EP-1075476-B1 | NOVEL BENZIMIDAZOLES AND BENZOXAZOLES | ALTANA PHARMA AG (DE) | 2003-06-04 | — | — | EP | disclosed |
| US-6294564-B1 | ACUTE OR CHRONIC AIRWAY DISORDER, A DERMATOSIS, A DISORDER BASED ON EXCESSIVE RELEASE OF TNF OR LEIKOTRIENE, A DISORDER OF GRAFT-VERSUS-HOST REACTION, A TRANSPLANT REJECTION REACTION, A SYMPTOM OF SHOCK, A GENERALIZED INFLAMMATION IN | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 2001-09-25 | — | — | US | disclosed |
| EP-1075476-A1 | NOVEL BENZIMIDAZOLES AND BENZOXAZOLES | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 2001-02-14 | — | — | EP | disclosed |
| WO-1999057115-A1 | NOVEL BENZIMIDAZOLES AND BENZOXAZOLES | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1999-11-11 | — | — | WO | disclosed |